Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q4 2021 vs. Q3 2021
How the institutions holding Kiora Pharmaceuticals Inc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 0 | 13 | +13 |
| Shares | 0 | 804.9K | +804.9K |
| Value | $0 | $1.22M | +$1.22M |
New holders (13)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 523,954 | $791.0K | 0.00% |
| Vanguard Group Inc | 151,702 | $229.0K | 0.00% |
| Price T Rowe Associates Inc | 51,300 | $77.0K | 0.00% |
| Jane Street Group, LLC | 31,232 | $47.0K | 0.00% |
| BlackRock Inc. | 20,981 | $32.0K | 0.00% |
| UBS Group AG | 20,473 | $31.0K | 0.00% |
| US Bancorp | 2,710 | $4.00K | 0.00% |
| Advisor Group Holdings, Inc. | 1,468 | $3.00K | 0.00% |
| Morgan Stanley | 334 | $1.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 347 | $1.00K | 0.00% |
| Bank of America Corp | 19 | $0 | 0.00% |
| Wells Fargo & Company | 78 | $0 | 0.00% |
| Albion Financial Group | 254 | $0 | 0.00% |
Sold out (0)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q3 2021 and filed for Q4 2021 without it.
None.